Inhibition of mammary carcinogenesis by flurbiprofen, a non-steroidal antiinflammatory agent.
about
Cyclooxygenase in the treatment of glioma: its complex role in signal transductionBortezomib in combination with celecoxib in patients with advanced solid tumors: a phase I trial.Overexpression of cyclooxygenase-2 in rat oral cancers and prevention of oral carcinogenesis in rats by selective and nonselective COX inhibitorsPotential utility of COX-2 inhibitors in chemoprevention and chemotherapy.Cyclooxygenase-2: a novel molecular target for the prevention and treatment of head and neck cancer.Current concepts in cyclooxygenase inhibition in breast cancer.Selective cyclooxygenase-2 inhibition: a target in cancer prevention and treatment.Anti-inflammation induced by counter-irritation or by treatment with non-steroidal agents inhibits the growth of a tumour of non-detected immunogenicityN-Methyl-N-nitrosourea as a mammary carcinogenic agent.In vitro effects of eicosanoid synthesis inhibitors in the presence of linoleic acid on MDA-MB-231 human breast cancer cells.Lung tumorigenicity of NNK given orally to A/J mice: its application to chemopreventive efficacy studies.Elevated expression of cyclooxygenase-2 is a negative prognostic factor for disease free survival and overall survival in patients with breast carcinoma.Inhibitory effects of nabumetone, a cyclooxygenase-2 inhibitor, and esculetin, a lipoxygenase inhibitor, on N-methyl-N-nitrosourea-induced mammary carcinogenesis in rats.Phorbol ester-mediated induction of cyclooxygenase-2 gene expression is inhibited by retinoids.COX-2 is expressed in human pulmonary, colonic, and mammary tumors.Enhancing effects of quinacrine on development of hepatopancreatic lesions in N-nitrosobis(2-oxopropyl)amine-initiated hamsters.Influence of esculetin on incidence, proliferation, and cell kinetics of mammary carcinomas induced by 7,12-dimethylbenz[a]anthracene in rats on high- and low-fat diets.
P2860
Q28168685-C0F17F92-3CCA-4373-A5D4-AA3A8D79224BQ33308317-F66C11B1-FC48-4C20-A945-3BE4A0974E87Q33584254-E04D74CF-F7B6-4047-A27F-734C4B849566Q34119511-B86D1C7A-141F-4479-94C9-DFEDF650A7E9Q34804039-464F65A5-3B5C-48F5-BBC3-6A69762FA2B8Q34969789-DB401E38-58C8-41EF-92C4-C5719D255FFBQ35043366-D915FC93-E74B-42D2-A441-2519EBD60F38Q36467968-5810238A-9CC5-4EA8-8FFF-F1ED4F21831DQ38589651-2052C7B6-FE8C-4167-9A9D-96E5C89F89E5Q41250767-6D3C0DCC-FB58-491C-974C-40309B4A2819Q43906717-8DBD8B06-93B0-4EFC-BBF6-4DDD4089FDE1Q44464279-035C7F16-029F-4812-B9CC-FF6ACA844152Q47759091-F9B73F15-0E61-414C-92AB-1F0444470CA7Q48003392-B7FC10C0-6200-452E-B8E3-FD83A8DF4E9EQ53402915-3C2BA25B-AC04-426C-8C66-6AF21E45870DQ53435478-E3A45BF7-DFA4-4A1D-9F89-C13D294C0B22Q53477861-25CB34D6-C87C-4472-BF5D-6453B147AB36
P2860
Inhibition of mammary carcinogenesis by flurbiprofen, a non-steroidal antiinflammatory agent.
description
1983 nî lūn-bûn
@nan
1983年の論文
@ja
1983年論文
@yue
1983年論文
@zh-hant
1983年論文
@zh-hk
1983年論文
@zh-mo
1983年論文
@zh-tw
1983年论文
@wuu
1983年论文
@zh
1983年论文
@zh-cn
name
Inhibition of mammary carcinog ...... roidal antiinflammatory agent.
@ast
Inhibition of mammary carcinog ...... roidal antiinflammatory agent.
@en
type
label
Inhibition of mammary carcinog ...... roidal antiinflammatory agent.
@ast
Inhibition of mammary carcinog ...... roidal antiinflammatory agent.
@en
prefLabel
Inhibition of mammary carcinog ...... roidal antiinflammatory agent.
@ast
Inhibition of mammary carcinog ...... roidal antiinflammatory agent.
@en
P2860
P356
P1476
Inhibition of mammary carcinog ...... roidal antiinflammatory agent.
@en
P2093
D L McCormick
P2860
P2888
P304
P356
10.1038/BJC.1983.278
P407
P577
1983-12-01T00:00:00Z